Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Rong

Showing results (411-420 of 482) with videos related to

Pageof 49
Sort By:
Bone Marrow Transplantation|May 10, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibodyYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Leukemia & Lymphoma|February 10, 2016
Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantationYing-Jun Chang, Hong-Tao Wang, Lan-Ping Xu, et al.
Annals of Hematology|March 13, 2021
Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantationJing Liu, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Frontiers in Immunology|February 14, 2022
Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry StudiesMeng-Zhu Shen, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Therapeutic Advances in Hematology|January 31, 2022
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-<i>versus</i>-host disease after haploidentical allogeneic hematopoietic stem cell transplantationMeng-Zhu Shen, Xin-Xin Liu, Zhi-Yuan Qiu, et al.
Bone Marrow Transplantation|August 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective studySi-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Psychiatry Research|July 16, 2013
Frequency and risk factors of workplace violence on psychiatric nurses and its impact on their quality of life in ChinaJiao-Ying Zeng, Feng-Rong An, Yu-Tao Xiang, et al.
Experimental Hematology & Oncology|May 3, 2022
A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantationMeng-Zhu Shen, Shen-Da Hong, Rui Lou, et al.
Annals of Hematology|March 24, 2018
IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCTXiao-Hui Zhang, Xin Zhao, Chen-Cong Wang, et al.
Bone Marrow Transplantation|January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factorsMeng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Pageof 49

Showing results (411-420 of 482) with videos related to

Sort By:
Pageof 49
Bone Marrow Transplantation|May 10, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibodyYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Leukemia & Lymphoma|February 10, 2016
Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantationYing-Jun Chang, Hong-Tao Wang, Lan-Ping Xu, et al.
Annals of Hematology|March 13, 2021
Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantationJing Liu, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Frontiers in Immunology|February 14, 2022
Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry StudiesMeng-Zhu Shen, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Therapeutic Advances in Hematology|January 31, 2022
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-<i>versus</i>-host disease after haploidentical allogeneic hematopoietic stem cell transplantationMeng-Zhu Shen, Xin-Xin Liu, Zhi-Yuan Qiu, et al.
Bone Marrow Transplantation|August 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective studySi-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Psychiatry Research|July 16, 2013
Frequency and risk factors of workplace violence on psychiatric nurses and its impact on their quality of life in ChinaJiao-Ying Zeng, Feng-Rong An, Yu-Tao Xiang, et al.
Experimental Hematology & Oncology|May 3, 2022
A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantationMeng-Zhu Shen, Shen-Da Hong, Rui Lou, et al.
Annals of Hematology|March 24, 2018
IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCTXiao-Hui Zhang, Xin Zhao, Chen-Cong Wang, et al.
Bone Marrow Transplantation|January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factorsMeng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Pageof 49